Pluryal Silk 1x2ml

• What Is Pluryal Silk?
• Polynucleotides 7.5 mg/ml – Composition and Action
• How the Product Works
• Treatment Results
• Indications and Treatment Areas
• Administration and Treatment Protocol
• Ingredients and Pack Contents
• Safety and Contraindications
• FAQ – Frequently Asked Questions

What Is Pluryal Silk?

Pluryal Silk is a viscoelastic, non-pyrogenic preparation based on polynucleotides, designed for skin revitalisation and regeneration. It has been developed for delicate, thin and demanding skin, including areas such as the eye contour, perioral area, neck and décolletage.

The preparation supports improvements in skin condition, hydration, elasticity and firmness. The treatment protocol aims to improve skin quality and restore a fresh, healthy appearance.

Polynucleotides 7.5 mg/ml – Composition and Action

Pluryal Silk contains polynucleotides at a concentration of 7.5 mg/ml. A 2 ml pre-filled syringe therefore contains a total of 15 mg of polynucleotides.

Polynucleotides are used in preparations designed to support skin regeneration processes. Pluryal Silk is intended for treatments aimed at improving skin quality, hydration and elasticity, including in delicate areas.

How the Product Works

When used as part of an appropriately selected treatment protocol, Pluryal Silk is intended to support:

• Skin regeneration and revitalisation.
• Improved hydration and overall skin condition.
• Support for collagen and elastin synthesis associated with improved skin quality.
• Improved skin elasticity and firmness.
• Improved skin tone and smoothness.

Treatment Results

• improved skin hydration,
• improved firmness and elasticity,
• smoother-looking skin,
• support for collagen and elastin synthesis,
• improved skin tone and radiance,
• skin revitalisation and nourishment,
• improved overall skin condition and a healthier appearance.

Indications and Treatment Areas

Pluryal Silk is intended for skin-regenerating and revitalising treatments for all skin types. The supplied materials identify the following treatment objectives:

• skin regeneration and revitalisation,
• hydration and nourishment,
• improved skin tone,
• improved elasticity and firmness,
• skin smoothing,
• support for collagen and elastin synthesis.

Treatment areas listed in the supplied descriptions:

• neck,
• décolletage,
• chest,
• abdomen,
• eye contour, including the delicate periocular area,
• perioral area,
• backs of the hands,
• inner arms.

The second supplied description also mentions delicate facial areas, including the upper eyelids. It additionally refers to use as an adjunct in the treatment of acne scars and alongside selected energy-based device treatments and chemical peels. These applications should be verified against the current product instructions for use.

Administration and Treatment Protocol

• Injection depth: dermis.
• Recommended needle size: 30G × 13 mm.
• Administration techniques: linear technique, point-by-point injections, cross-linear technique, or a combination of techniques.
• Younger skin: 3 treatments at 3-week intervals, followed by a maintenance treatment every 2–3 months.
• Mature skin: 4 treatments at 3-week intervals, followed by a maintenance treatment every month.

These schedules reflect the information provided in the supplied materials. Before treatment, their consistency with the current product instructions for use should be confirmed. The protocol should be adapted to the patient's assessment and the judgement of a qualified practitioner.

Ingredients and Pack Contents

• Active ingredient: polynucleotides – 7.5 mg/ml.
• Total polynucleotide content: 15 mg in a 2 ml pre-filled syringe.
• Form: viscoelastic, non-pyrogenic injectable preparation.
• Pack contents: 1 × 2 ml pre-filled syringe and 2 × 30G × 13 mm needles.

Ingredients: Polynucleotides, Water for injectable preparations, Sodium Chloride, Sodium Phosphate, Monobasic Dihydrate, Sodium Phosphate Dibasic Dodecahydrate.

Safety and Contraindications

Before use, consult the current product instructions for use and assess the patient's suitability for treatment. The supplied materials do not include a complete list of contraindications, so this information should not be supplemented with assumptions.

Contraindications, warnings and possible adverse reactions should be checked in the manufacturer's documentation, with particular attention to hypersensitivity to the ingredients and the condition of the skin at the intended treatment site.

FAQ – Frequently Asked Questions

What concentration of polynucleotides does Pluryal Silk contain?

Pluryal Silk contains polynucleotides at a concentration of 7.5 mg/ml. The 2 ml pre-filled syringe contains a total of 15 mg of polynucleotides.

Which areas can be treated with Pluryal Silk?

The supplied materials list the neck, décolletage, chest, abdomen, eye contour, perioral area, backs of the hands and inner arms. The second description also mentions the upper eyelids and selected adjunctive applications involving acne scars, energy-based device treatments and chemical peels.

Which needle size is recommended in the product description?

The supplied materials specify a 30G × 13 mm needle.

Which administration techniques are listed?

The supplied materials list the linear technique, point-by-point injections, the cross-linear technique, or a combination of techniques.

How many treatments are included in the protocol?

According to the supplied information, the protocol for younger skin consists of 3 treatments at 3-week intervals, followed by maintenance every 2–3 months. For mature skin, 4 treatments at 3-week intervals are indicated, followed by monthly maintenance. The schedule should be confirmed against the current product instructions for use.

This product is intended for use by appropriately qualified professionals in accordance with the current instructions for use and applicable regulations. Before use, consult the manufacturer's documentation and ensure that the patient has been appropriately assessed for treatment.